Another Acadia presentation coming up early next morning with the Needham Virtual on Monday 345pm ET.
Personally hoping to get confirmation Daybue has returned to previous sales levels and the January dip is history. Uncertainty on this front could be something that would put the brakes on a rise into the Pitt Hopkins results. PMS had great Q3 numbers to bolster sentiment on the run in to those stellar results. One could argue that December outcome may be all that's needed to fire up expectations for the next Phase 2 results.
Possible other things of interest to Neuren shareholders would be talk of Fragile X trials on the horizon although not sure this will be the forum, we'll see.
Acadia, page-412
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$16.57 |
Change
2.170(15.1%) |
Mkt cap ! $2.117B | |||
| Open | High | Low | Value | Volume |
| $14.85 | $16.67 | $14.60 | $24.77M | 1.544M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1500 | $16.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.57 | 1717 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |